Cargando…
Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
In most acute promyelocytic leukemia (APL) cells, promyelocytic leukemia (PML) fuses to retinoic acid receptor α (RARα) due to chromosomal translocation, thus generating PML/RARα oncoprotein, which is a relatively stable oncoprotein for degradation in APL. Elucidating the mechanism regulating the st...
Autores principales: | Shao, Xuejing, Chen, Yingqian, Wang, Wei, Du, Wenxin, Zhang, Xingya, Cai, Minyi, Bing, Shaowei, Cao, Ji, Xu, Xiaojun, Yang, Bo, He, Qiaojun, Ying, Meidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279643/ https://www.ncbi.nlm.nih.gov/pubmed/35847510 http://dx.doi.org/10.1016/j.apsb.2021.10.020 |
Ejemplares similares
-
Genome-wide functions of PML–RARα in acute promyelocytic leukaemia
por: Saeed, S, et al.
Publicado: (2011) -
Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides
por: Beez, Sabine, et al.
Publicado: (2012) -
PML‐RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia
por: Yang, Xianwen, et al.
Publicado: (2018) -
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017) -
HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse
por: Coltella, Nadia, et al.
Publicado: (2014)